Navigation Links
VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration
Date:8/4/2009

MELBOURNE, Australia, Aug. 4 /PRNewswire-FirstCall/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced the results of its clinical trial demonstrating that VivaGel(R) retains antiviral activity against human immunodeficiency virus (HIV) and herpes simplex virus (HSV, the virus that causes genital herpes), following vaginal administration in women.

The clinical study was conducted to assess the antiviral activity of VivaGel(R) (SPL7013 Gel) in cervicovaginal fluid samples (CVS) taken from healthy women immediately, then at 1, 3, 12 and 24 hours after separate vaginal doses of the product. These samples were tested for their ability to prevent HIV and genital herpes (HSV-2) infection of susceptible cells in the laboratory.

The study showed that CVS obtained immediately after vaginal administration of VivaGel(R) provided effectively complete inhibition of HIV and HSV infection in vitro.

At 1 and 3 hours following administration of product, the initial high level of inhibition of HIV and HSV was retained in all women tested.

Even at 12 and 24 hours following administration, more than 90% of the initial antiviral activity was retained for both HIV and HSV in more than half of the women enrolled in the study.

This is the first clinical study to demonstrate potent antiviral activity of any microbicide beyond one hour after administration of the product in humans. These data indicate the potential for VivaGel(R) to be used other than immediately prior to sexual intercourse (i.e., as a coitally-dissociated microbicide). However, future testing in clinical efficacy studies is required to confirm this.

"These results are extremely encouraging," said Dr Jackie Fairley, CEO of Starpharma. "They show not only an excellent level of activity, but also a sustainability of effect that exceeded our expectations.
'/>"/>

SOURCE Starpharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Warning for N-9 - an Opportunity for VivaGel(R)
2. Starpharma and Durex Sign Co-Development Agreement for VivaGel(R)-Coated Condoms
3. CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges
4. Study demonstrates the anti-inflammatory properties of pine bark extract
5. Study Demonstrates the Anti-Inflammatory Properties of Pine Bark Extract on Inflammatory Mediators COX-2 and 5-LOX
6. Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
7. Clinical Study Demonstrates Superior Bioavailability of Jarrow's Proprietary QH-absorb Formula
8. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
9. Penn study demonstrates new way to boost immune memory
10. Study Demonstrates Internet Risks for Teen Girls
11. Abbotts XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, Real World Patients in SPIRIT V Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... November 28, 2014 Lice Troopers Lice Removal ... its in-home head lice service for moms in Miami-Dade ... center of Coral Gables on Pone De-leon Blvd in Miami. ... Islands that service Miami-Dade & Broward. Lice Troopers is ... South Florida which has been treating families for several years. ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 "Most of my ... me to use crutches," said an inventor from Findlay, Ohio. ... convenient way to support my foot, which inspired me to ... to offer a convenient way to support an injured foot. ... around. It eliminates the need for crutches. The design redistributes ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
(Date:11/28/2014)... Brentwood, TN (PRWEB) November 28, 2014 ... in Tennessee for the first time. PAI Medical Group ... M.D. will be performing a robotic hair transplant procedure ... at 9:00 A.M. , The first in Tennessee and ... PAI Medical Group now offers ARTAS robotic hair transplantation. ...
(Date:11/28/2014)... Most of the people attending a presentation by Ken Farmer ... Woods retirement community found out the “prized” possessions they ... have made the cut to be on an “Antiques Roadshow” ... and folk art and his appearances on the PBS program ... and selling antiques. Broadly speaking the antiques market is ...
Breaking Medicine News(10 mins):Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Antiques Appraiser Sheds Light on "Treasures" 2
... Food and Drug Administration (FDA) and Roxane Labs have ... are used in patients with severe// rheumatoid arthritis as ... ,"It was discovered that a single bottle of ... 2.5 mg. While we believe this issue may be ...
... local newspaper to pay compensation and apologise to a young ... unethical reporting.// ,Beijing Chaoyang District Court ordered the ... (2,500 US dollars) and issue an apology on its front ... carried three photos of the woman and the story of ...
... companies have evinced interest to invest in India ... committing Rs 1,665 crore investment for capacity expansion ... and Fertilisers Minister Ram Vilas Paswan said here. ... to Japan recently, said during his trip significant ...
... is not healthy to lose weight soon after giving birth, ... the pitfalls of following celebrity trends//, and aspiring for an ... serious effects on the health of the mother and the ... the baby’s birth, is a time for building nutrition ...
... Health (MOH) says that Singapore will soon conduct a ... Readiness.// , More than 1,000 personnel from ... of Education, the Civil Aviation Authority of Singapore, Immigration ... in the exercise code-named SPARROWHAWK II. , ...
... lakh equity shares to Ranbaxy Laboratories on a preferential basis ... directors has approved the issue of 20 lakh equity shares ... a preferential basis to Ranbaxy, subject to shareholders' approval, the ... approved the allotment of shares over 1.11 crore equity shares ...
Cached Medicine News:
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
(Date:11/26/2014)... and NEW YORK ... As the leading distributor of market intelligence, ... new research report by IQ4I Research and Consultancy focusing ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast to ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Beginning today, Northside Hospital and Atlanta Perinatal Consultants announce ... test for common fetal trisomies, such as trisomy 21 ... Edwards syndrome. The Harmony Prenatal Test, ... testing platform to analyze DNA in maternal blood so ...
... 26, 2012 Quest International, Inc., a leading global ... solutions, announced today that is has contributed $5000 to ... the American Cancer Society Key Gala, that benefits the ... Massachusetts on Thursday, March 29, 2012. "We ...
Cached Medicine Technology:Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 2Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 3Quest International Donates $5000 to the American Cancer Society 2
Stainless steel lockable wall display for up to 12 frames....
... display system provides maximum impact for the ... unique approach to displaying frames allows your ... create appealing, flexible and eye-catching displays. The ... your patients are motivated. Removable holders. Variable ...
Single Eyevee 2.0 Frame Clip. Available in black, clear and silver colors....
... ClinicDB is a multi-page ... that maintains a database of ... microscopy results, adverse reactions, etc. ... reports, letters and invoices that ...
Medicine Products: